1219802-37-5
1219802-37-5
Chemical Structure
3-Pyridylacetic acid-d4 hydrochloride
- CAS No.: 1219802-37-5
- Formula:C7H4D4ClNO2
- Molecular Weight:177.62
InChIKey: XVCCOEWNFXXUEV-BONYUCOBSA-N
SMILES: [2H]OC(C([2H])([2H])C1=CN=CC=C1)=O.Cl[2H]
Biological Activity: 3-Pyridylacetic acid-d4 (hydrochloride) is the deuterium labeled 3-Pyridylacetic acid hydrochloride[1]. 3-Pyridineacetic acid hydrochloride is a higher homologue of nicotinic acid, a breakdown product of nicotine (and other tobacco alkaloids)[2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-Pyridylacetic acid-d4 hydrochloride | 3-Pyridylacetic acid-d4 (hydrochloride) is the deuterium labeled 3-Pyridylacetic acid hydrochloride. 3-Pyridineacetic acid hydrochloride is a higher homologue of nicotinic acid, a breakdown product of nicotine (and other tobacco alkaloids). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Pyridylacetic acid hydrochloride (Standard) | ≥98% | 3-Pyridylacetic acid (hydrochloride) (Standard) is the analytical standard of 3-Pyridylacetic acid (hydrochloride). This product is intended for research and analytical applications. 3-Pyridineacetic acid hydrochloride is a higher homologue of nicotinic acid, a breakdown product of nicotine (and other tobacco alkaloids). 3-Pyridylacetic acid hydrochloride can be used to synthesize anti-inflammatory agents or as a precursor for the preparation of herbicides. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Pyridylacetic acid hydrochloride | 99.72% | 3-Pyridineacetic acid hydrochloride is a high homolog of nicotinic acid and is a decomposition product of nicotine (and other tobacco alkaloids). 3-Pyridylacetic acid hydrochloride can be used to synthesize anti-inflammatory agents or as a precursor for the preparation of herbicides. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. GINOULHIAC E, et al. 3-Pyridineacetic acid and nicotinic acid: blood levels, urinary elimination and excretion of nicotinic acid derivatives in man. Nature. 1962 Mar 10;193:948-9. [Content Brief]
- [3]. Zwickenpflug W, et al. Metabolism of myosmine in Wistar rats. Drug Metab Dispos. 2005 Nov33(11):1648-56. [Content Brief]
